News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,756 Results
Type
Article (14907)
Company Profile (299)
Press Release (266544)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79836)
Career Advice (162)
Deals (13337)
Drug Delivery (39)
Drug Development (50705)
Employer Resources (31)
FDA (5838)
Job Trends (5168)
News (145084)
Policy (10071)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (19)
Adcomms (14)
Allergies (84)
Alliances (21761)
ALS (126)
Alzheimer's disease (1034)
Antibody-drug conjugate (ADC) (242)
Approvals (6032)
Artificial intelligence (264)
Autoimmune disease (117)
Automation (9)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (345)
Cancer (3146)
Cardiovascular disease (239)
Career advice (147)
Career pathing (7)
CAR-T (222)
CDC (5)
Cell therapy (573)
Cervical cancer (14)
Clinical research (43706)
Collaboration (1161)
Company closure (2)
Compensation (599)
Complete response letters (40)
COVID-19 (1101)
CRISPR (86)
C-suite (559)
Cystic fibrosis (112)
Data (4346)
Denatured (15)
Depression (93)
Diabetes (256)
Diagnostics (1382)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (195)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (217)
Earnings (31657)
Editorial (26)
Employer branding (4)
Employer resources (29)
Events (51691)
Executive appointments (626)
FDA (7600)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (991)
Gene editing (183)
Generative AI (22)
Gene therapy (494)
GLP-1 (507)
Government (1148)
Grass and pollen (3)
Guidances (166)
Healthcare (6611)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (193)
Immuno-oncology (42)
Indications (69)
Infectious disease (1208)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (167)
Interviews (18)
IPO (7346)
IRA (12)
Job creations (867)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1400)
Liver cancer (41)
Longevity (11)
Lung cancer (423)
Lymphoma (250)
Machine learning (24)
Management (7)
Manufacturing (379)
MASH (131)
Medical device (2664)
Medtech (2673)
Mergers & acquisitions (6621)
Metabolic disorders (731)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (233)
Neuropsychiatric disorders (70)
Neuroscience (1961)
Neurotech (1)
NextGen: Class of 2026 (2034)
Non-profit (866)
Now hiring (31)
Obesity (332)
Opinion (125)
Ovarian cancer (132)
Pain (102)
Pancreatic cancer (162)
Parkinson's disease (232)
Partnered (12)
Patents (302)
Patient recruitment (337)
Peanut (44)
People (26672)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15487)
Phase 2 (20310)
Phase 3 (12826)
Pipeline (3320)
Policy (90)
Postmarket research (853)
Preclinical (6539)
Press Release (30)
Prostate cancer (146)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (658)
Real estate (1448)
Recruiting (12)
Regulatory (9912)
Reports (19)
Research institute (972)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (184)
Series B (140)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (338)
Venture capital (69)
Weight loss (174)
Women's health (26)
Worklife (2)
Date
Today (67)
Last 7 days (358)
Last 30 days (1164)
Last 365 days (17884)
2026 (1844)
2025 (18098)
2024 (20543)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7615)
2010 (7428)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18266)
Australia (3112)
California (7110)
Canada (1847)
China (780)
Colorado (248)
Connecticut (252)
Delaware (236)
Europe (39195)
Florida (908)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (36)
Indiana (161)
Iowa (8)
Japan (227)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (738)
Massachusetts (5611)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1651)
New Mexico (13)
New York (1771)
North Carolina (835)
North Dakota (6)
Northern California (3499)
Ohio (179)
Oklahoma (11)
Oregon (24)
Pennsylvania (1284)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2817)
Tennessee (40)
Texas (915)
United States (23447)
Utah (97)
Virginia (137)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (46)
281,756 Results for "starton therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Starton Therapeutics to Present at Biotech Showcase 2026
December 17, 2025
·
2 min read
Press Releases
Starton Therapeutics Announces Promotion of Rod Hartwig to Vice President of Research and Development and Manufacturing
October 3, 2025
·
3 min read
Press Releases
Starton Therapeutics to Share Innovative Lenalidomide Delivery Technology on Labroots Webinar Sponsored by Primetech Corporation
October 9, 2025
·
6 min read
Press Releases
Starton Therapeutics to Participate in Panel at Longwood Healthcare Leaders Boston CEO, October 27-28, 2025
October 2, 2025
·
4 min read
Press Releases
Starton Therapeutics Granted New U.S. Patent #12,390,457 Titled “Stable Solutions of Immunomodulatory Imide Compounds for Parenteral Use” a Formulation of STAR-LLD
September 17, 2025
·
4 min read
Press Releases
Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)
June 24, 2025
·
4 min read
Pharm Country
Starton Therapeutics to Present at BIO CEO & Investor Conference 2024
Starton Therapeutics Inc. (“Starton” or the “Company”) today announced that Pedro Lichtinger, Chairman and Chief Executive Officer of Starton Therapeutics, will present and host one-on-one meetings at the BIO CEO & Investor Conference being held in New York City, February 26-27, 2024.
February 23, 2024
·
1 min read
Press Releases
Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment
June 13, 2025
·
4 min read
Pharm Country
Starton Therapeutics Announces STARTICLES Filing
Starton Therapeutics Inc. (“Starton” or the “Company”) announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for Solid State Active Pharmaceutical Composition for Transdermal Drug Delivery, referred to by the Company as STARTICLES.
January 17, 2024
·
3 min read
Pharm Country
Starton Therapeutics to Present at Upcoming MedInvest and Needham Conferences
Starton Therapeutics Inc. will present and host one-on-one meetings at the MedInvest Biotech & Pharma Investor and 23rd Annual Needham Virtual Healthcare Conferences.
March 25, 2024
·
1 min read
1 of 28,176
Next
